No connection

Search Results

IINN vs LPCN

IINN
Inspira Technologies Oxy B.H.N. Ltd.
BEARISH
Price
$0.42
Market Cap
$18.5M
Sector
Healthcare
AI Confidence
95%
LPCN
Lipocine Inc.
BEARISH
Price
$2.38
Market Cap
$17.4M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
IINN
--
LPCN
--
Forward P/E
IINN
-0.61
LPCN
-1.92
P/B Ratio
IINN
6.54
LPCN
1.01
P/S Ratio
IINN
64.07
LPCN
8.79
EV/EBITDA
IINN
-1.18
LPCN
-0.29

Profitability

Gross Margin
IINN
0.69%
LPCN
100.0%
Operating Margin
IINN
-4713.84%
LPCN
-219.65%
Profit Margin
IINN
0.0%
LPCN
0.0%
ROE
IINN
-397.89%
LPCN
-54.28%
ROA
IINN
-126.98%
LPCN
-32.81%

Growth

Revenue Growth
IINN
--
LPCN
-67.2%
Earnings Growth
IINN
--
LPCN
--

Financial Health

Debt/Equity
IINN
0.21
LPCN
0.03
Current Ratio
IINN
1.56
LPCN
6.68
Quick Ratio
IINN
1.12
LPCN
6.36

Dividends

Dividend Yield
IINN
--
LPCN
--
Payout Ratio
IINN
0.0%
LPCN
0.0%

AI Verdict

IINN BEARISH

IINN exhibits severe fundamental distress, characterized by a Piotroski F-Score of 4/9, which barely maintains a 'stable' rating despite catastrophic operational metrics. The company's operating margin of -4713.84% and a Price-to-Sales ratio of 64.07 indicate a massive disconnect between market valuation and actual revenue generation. With a 5-year price decline of 91% and a technical trend score of 0/100, the stock is in a persistent freefall. The absence of an Altman Z-Score and Graham Number further underscores the lack of positive earnings or stable equity to support a traditional valuation.

Strengths
Low Debt/Equity ratio (0.21)
Current Ratio of 1.56 suggests adequate short-term liquidity
Quick Ratio of 1.12 indicates ability to cover immediate liabilities
Risks
Extreme operational inefficiency (Operating Margin: -4713.84%)
Negligible Gross Margin (0.69%) suggesting no pricing power or high COGS
Severe valuation bubble relative to sales (P/S: 64.07)
LPCN BEARISH

LPCN exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 0/9, indicating severe deterioration across all financial health dimensions. While the company maintains a strong liquidity position with a current ratio of 6.68 and negligible debt, these are offset by a catastrophic 67.2% year-over-year revenue collapse and an operating margin of -219.65%. The technical trend is entirely bearish (0/100), and the stock has lost over 90% of its value over five years. Despite a lone analyst's optimistic $11.00 target, the data suggests a company in operational distress.

Strengths
Very low debt-to-equity ratio (0.03)
Strong short-term liquidity (Current Ratio 6.68)
Trading near book value (P/B 1.01)
Risks
Severe revenue decline (-67.2% YoY)
Critical financial health score (Piotroski 0/9)
Extreme negative operating margins (-219.65%)

Compare Another Pair

IINN vs LPCN: Head-to-Head Comparison

This page compares Inspira Technologies Oxy B.H.N. Ltd. (IINN) and Lipocine Inc. (LPCN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile